Variability of preoperative breast MRI utilization among older women with newly diagnosed early-stage breast cancer

Breast Journal

Volumn 19, Issue 6, 2013, Pages 627-636

  Wang, Shi Yi ^a,b   Virnig, Beth A ^b   Tuttle, Todd M ^c   Jacobs, David R ^b   Kuntz, Karen M ^b   Kane, Robert L ^b  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

breast cancer; magnetic resonance imaging; median odds ratio; practice variation; preoperative evaluation

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER SURGERY; EARLY CANCER; ECHOMAMMOGRAPHY; ELDERLY CARE; HEALTH CARE UTILIZATION; MAMMOGRAPHY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION;

BREAST CANCER; MAGNETIC RESONANCE IMAGING; MEDIAN ODDS RATIO; PRACTICE VARIATION; PREOPERATIVE EVALUATION;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING;

EID: 84886801965     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12177     Document Type: Article

References (35)

1. Fischer U, Baum F, Luftner-Nagel S,. Preoperative MR imaging in patients with breast cancer: preoperative staging, effects on recurrence rates, and outcome analysis. Magn Reson Imaging Clin N Am 2006; 14: 351-62.
2. Hede K, Preoperative MRI,. in breast cancer grows contentious. J Natl Cancer Inst 2009; 101: 1667-9.
3. Sardanelli F,. Overview of the role of pre-operative breast MRI in the absence of evidence on patient outcomes. Breast 2010; 19: 3-6.
4. Solin LJ,. Counterview: pre-operative breast MRI (magnetic resonance imaging) is not recommended for all patients with newly diagnosed breast cancer. Breast 2010; 19: 7-9.
5. Lehman CD, DeMartini W, Anderson BO, Edge SB,. Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Canc Netw 2009; 7: 193-201.
6. Houssami N, Hayes DF,. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin 2009; 59: 290-302.
7. Solin LJ, Orel SG, Hwang WT, Harris EE, Schnall MD,. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008; 26: 386-91.
8. Hwang N, Schiller DE, Crystal P, Maki E, McCready DR,. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann Surg Oncol 2009; 16: 3000-9.
9. Turnbull L, Brown S, Harvey I, et al,. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 2010; 375: 563-71.
10. Bleicher RJ, Ciocca RM, Egleston BL, et al,. The association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 2009; 209: 180-7.
11. Hulvat M, Sandalow N, Rademaker A, Helenowski I, Hansen NM,. Time from diagnosis to definitive operative treatment of operable breast cancer in the era of multimodal imaging. Surgery 2010; 148: 746-50; discussion 750-751.
12. Liberman L, Mason G, Morris EA, Dershaw DD,. Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. AJR Am J Roentgenol 2006; 186: 426-30.
13. Lehman CD, Gatsonis C, Kuhl CK, et al,. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007; 356: 1295-303.
14. Miller BT, Abbott AM, Tuttle TM,. The Influence of Preoperative MRI on breast cancer treatment. Ann Surg Oncol 2012; 19: 536-40.
15. Sommer CA, Stitzenberg KB, Tolleson-Rinehart S, Carpenter WR, Carey TS,. Breast MRI utilization in older patients with newly diagnosed breast cancer. J Surg Res 2011; 170: 77-83.
16. Fischer U, Zachariae O, Baum F, von Heyden D, Funke M, Liersch T,. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004; 14: 1725-31.
17. Pickles MD, Lowry M, Manton DJ, Gibbs P, Turnbull LW,. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005; 91: 1-10.
18. SEER-Medicare Linked Database. Available at: http://healthservices. cancer.gov/seermedicare/overview/ (accessed September 20, 2010).
19. Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL,. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 2002; 40 (8 Suppl IV): 19-25.
20. Klabunde CN, Warren JL, Legler JM,. Assessing comorbidity using claims data: an overview. Med Care 2002; 40 (8 Suppl IV): 26-35.
21. Baldwin LM, Adamache W, Klabunde CN, Kenward K, Dahlman C, L Warren J,. Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement. Med Care 2002; 40 (8 Suppl IV): 82-95.
22. Mittlbock M, Schemper M,. Explained variation for logistic regression. Stat Med 1996; 15: 1987-97.
23. Larsen K, Merlo J,. Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression. Am J Epidemiol 2005; 161: 81-8.
24. Bassett LW, Dhaliwal SG, Eradat J, et al,. National trends and practices in breast MRI. Am J Roentgenol 2008; 191: 332-9.
25. Katipamula R, Degnim AC, Hoskin T, et al,. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative MRI. J Clin Oncol 2009; 27: 4082-8.
26. Dang CM, Zaghiyan K, Karlan SR, Phillips EH,. Increased use of MRI for breast cancer surveillance and staging is not associated with increased rate of mastectomy. Am Surg 2009; 75: 937-40.
27. Report to the Congress: medicare payment policy. Medicare Payment Advisory Commission. Available at: http://www.medpac.gov/documents/Mar06- EntireReport.pdf (accessed September 20, 2009).
28. Morrow M,. Magnetic resonance imaging in the breast cancer patient: curb your enthusiasm. J Clin Oncol 2008; 26: 352-3.
29. Peters NH, van den Bosch MA, Peeters PH, Mali WM, Borel Rinkes IH,. Breast magnetic resonance imaging in early-stage breast cancer: is there really no value? J Clin Oncol 2008; 26: 3465-6; author reply 3466-3467.
30. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW,. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. J Am Med Assoc 2001; 285: 885-92.
31. Schouten van der Velden AP, Schlooz-Vries MS, Boetes C, Wobbes T,. Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review. Am J Surg 2009; 198: 262-9.
32. Turnbull LW, Brown SR, Olivier C, et al,. Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Health Technol Assess 2010; 14: 1-182.
33. Wennberg JE,. Dealing with medical practice variations: a proposal for action. Health Aff 1984; 3: 6-32.
34. Yau EJ, Gutierrez RL, DeMartini WB, Eby PR, Peacock S, Lehman CD,. The utility of breast MRI as a problem-solving tool. Breast J 2011; 17: 273-80.
35. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF,. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002; 40 (8 Suppl IV): 3-18.